Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 102 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

4%

4 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

40 recruiting

Enrollment Performance

Analytics

N/A
26(63.4%)
Phase 2
10(24.4%)
Phase 3
3(7.3%)
Phase 1
1(2.4%)
Phase 4
1(2.4%)
41Total
N/A(26)
Phase 2(10)
Phase 3(3)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (102)

Showing 20 of 102 trials
NCT06846112Not ApplicableActive Not Recruiting

Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy

Role: lead

NCT07258186Recruiting

Generation of Endometrial Carcinoma Organoids

Role: lead

NCT07256769Recruiting

Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis

Role: lead

NCT07248878Recruiting

Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy

Role: lead

NCT06224244Phase 2Active Not Recruiting

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients

Role: lead

NCT07065825Not Yet Recruiting

Tumor Rupture During Robotic Partial Nephrectomy

Role: collaborator

NCT04848493Completed

National Project on Vaccines, COVID-19 and Frail Patients

Role: collaborator

NCT07018037Recruiting

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

Role: lead

NCT06992986Recruiting

Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

Role: lead

NCT06992973Not ApplicableRecruiting

Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases

Role: lead

NCT05776758Phase 3Active Not Recruiting

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Role: lead

NCT06894628Recruiting

Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation

Role: lead

NCT06891664Not ApplicableActive Not Recruiting

Feasibility of Day-surgery Management for Patients Undergoing Robotic Radical Prostatectomy: a Randomized Trial

Role: lead

NCT06883214Recruiting

Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application

Role: lead

NCT06883201Recruiting

Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer

Role: lead

NCT06880289Phase 2Active Not Recruiting

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

Role: lead

NCT06878027Recruiting

Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool

Role: lead

NCT06877910Active Not Recruiting

Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer

Role: lead

NCT06875414Recruiting

Breast Cancer and Resilience in Couple

Role: lead

NCT06841653Recruiting

A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.

Role: lead